Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heron Therapeutics

2.05
-0.0600-2.84%
Post-market: 2.050.00000.00%18:49 EDT
Volume:2.70M
Turnover:5.64M
Market Cap:312.76M
PE:-36.53
High:2.19
Open:2.15
Low:2.04
Close:2.11
Loading ...
Mar 25, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 09, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 04, 2021

Major Issues Report

8-K - Current report
Sep 24, 2021

Major Issues Report

8-K - Current report
Sep 14, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 10, 2021

Correspondence

CORRESP [Cover] - Correspondence